Physician profile
Noah Russell
NPI 1619611407
$1,752.93
in general payments reported to CMS, 2019-2025
16 companies · $973 in 2025
The $973 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $48.28 · 2024: $731 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280 · Education: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.14 |
| Education | $472.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $567.55 | 2025 | Resolute Onyx, Ffrangio |
| Abiomed | $246.05 | 2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $208.55 | 2024-2025 | Fasenra, Andexxa, Breztri |
| Philips North America LLC | $165.65 | 2025 | Ambulatory Monitoring & Diagnostics Undivided, Coronary Other |
| Esperion Therapeutics, INC. | $122.56 | 2024 | Nexletol, Nexlizet |
| Daiichi Sankyo INC. | $100.25 | 2025 | Injectafer |
| Bridgebio Pharma, INC. | $68.38 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $66.15 | 2024 | Camzyos |
| Abbvie INC. | $59.92 | 2024 | |
| Merck Sharp & Dohme LLC | $36.99 | 2025 | Verquvo |
| Dexcom, INC. | $25.09 | 2023 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $23.19 | 2023 | Tlando, Xyosted, Nocdurna |
| Boston Scientific Corporation | $16.52 | 2024 | Watchman Flx |
| Exact Sciences Corporation | $16.28 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $16.05 | 2024 | Otezla |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $13.75 | 2024 | Xerava |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.